Series B - Viracta Therapeutics
Investment Firm
Overview
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Announced Date
Apr 04, 2017
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
4
Round Details and Background
Viracta Therapeutics raised $18400000 on 2017-04-04 in Series B
Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.
Company Funding History
10
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 02, 2007 |  Series A - Viracta Therapeutics | 3 | - | 20.0M |
| Mar 07, 2012 | Venture Round - Viracta Therapeutics | - | 6.5M | |
| Mar 12, 2012 | Series B - Viracta Therapeutics | 5 | - | 13.0M |
| Apr 21, 2010 | Series B - Viracta Therapeutics | 4 | - | 12.0M |
Recent Activity
There is no recent news or activity for this profile.